ARCHIVES

Cancer Groups Urge FDA To Spell Out Standards For Data Collection In Time-To-Progression Trials.

This article is from The Cancer Letter archive.

Vol. 34 No. 41 | November 7, 2008

Download PDF Visit The Full Archive

Related Articles

Paraplatin Lengthened TTP In HER2+ Advanced Breast Ca

January 31, 2003

DRCCA Board, ACCI Agree On New Core Grant Guidelines

February 6, 1981

Study Underway To Help Childhood Cancer Survivors With Learning Difficulties

October 26, 2001

Socio-Economic Factors, Access To Care, Associated With More Aggressive Cancers

April 27, 2007

Compendium Drops Listing of Aranesp for Anemia of Cancer.

February 23, 2007

USPSTF and ACS Recommend Less Frequent Cervical Cancer Screenings and Pap Smears

March 30, 2012